文献速递心境障碍

低收入和中等收入国家抑郁症心理治疗:一项荟萃分析

Psychotherapies for depression in low- and middle-income countries: a meta-analysis.
PubMed 文献 · World Psychiatry · 2018-01-01

该荟萃分析纳入253项随机对照试验,其中32项在非西方国家进行,评估西方开发的抑郁症心理治疗在非西方国家的效果。非西方国家心理治疗效应量大(g=1.10),校正发表偏倚后降至g=0.73,且显著大于西方国家研究;但异质性高,非西方国家效应量更大可能反映真实差异、对照条件差异或试验质量较低。

要点

  • 非西方国家心理治疗抑郁症效应量大(g=1.10),校正发表偏倚后为g=0.73。
  • 非西方国家效应量显著大于西方国家,校正参与者、治疗和研究特征后仍显著。
  • 对当地情况的适配与效应量无关,西方开发的心理治疗在非西方国家可能不更有效但可能不更差。

核心结论

  • 西方开发的心理治疗在非西方国家可能不更有效,但可能不更差,因此也可在这些国家使用。

研究设计与样本

  • 系统检索文献数据库的荟萃分析,纳入253项随机对照试验,其中32项在非西方国家进行。

主要发现

  • 非西方国家心理治疗效应量大(g=1.10;95% CI:0.91-1.30),异质性高(I2=90;95% CI:87-92)。
  • 校正发表偏倚后效应量降至g=0.73(95% CI:0.51-0.96)。
  • 亚组分析未显示对当地情况的适配与效应量相关。
  • 与西方国家研究比较,非西方国家效应量显著更大,校正参与者、治疗和研究特征后仍显著。

关键数值与推荐

  • 非西方国家心理治疗效应量g=1.10(95% CI:0.91-1.30),校正发表偏倚后g=0.73(95% CI:0.51-0.96)。
  • 异质性I2=90(95% CI:87-92)。

临床怎么用

  • 西方开发的心理治疗可考虑用于非西方国家,但需注意证据质量与对照条件差异。

局限性

  • 非西方国家效应量更大可能反映真实差异、对照条件为无可用照护或试验质量相对较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most psychotherapies for depression have been developed in high-income Western countries of North America, Europe and Australia. A growing number of randomized trials have examined the effects of these treatments in non-Western countries. We conducted a meta-analysis of these studies to examine whether these psychotherapies are effective and to compare their effects between studies from Western and non-Western countries. We conducted systematic searches in bibliographical databases and included 253 randomized controlled trials, of which 32 were conducted in non-Western countries. The effects of psychotherapies in non-Western countries were large (g=1.10; 95% CI: 0.91-1.30), with high heterogeneity (I2 =90; 95% CI: 87-92). After adjustment for publication bias, the effect size dropped to g=0.73 (95% CI: 0.51-0.96). Subgroup analyses did not indicate that adaptation to the local situation was associated with the effect size. Comparisons with the studies in Western countries showed that the effects of the therapies were significantly larger in non-Western countries, also after adjusting for characteristics of the participants, the treatments and the studies. These larger effect sizes in non-Western countries may reflect true differences indicating that therapies are indeed more effective; or may be explained by the care-as-usual control conditions in non-Western countries, often indicating that no care was available; or may be the result of the relative low quality of many trials in the field. This study suggests that psychotherapies that were developed in Western countries may or may not be more effective in non-Western countries, but they are probably no less effective and can therefore also be used in these latter countries.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cuijpers P, Karyotaki E, Reijnders M, et al. Psychotherapies for depression in low- and middle-income countries: a meta-analysis. World Psychiatry. 2018. PMID: 29352530. doi:10.1002/wps.20493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。